companies / fathomtherapeutics-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-21 json
| total_raised | 65,000,00065.0M | ○ |
|---|---|---|
| founded | 2019 | |
| hq | Boston, US | |
| industry | unknown | |
| stage | series-a |
Fathom Therapeutics uses physics-based simulation and AI to model protein motion at atomic resolution. It serves internal programs and pharma partners pursuing undruggable targets. Its Microcosmos platform speeds protein-dynamics modeling up to 10,000 times for more precise molecules.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-04-27 | series-a | 47,000,00047.0M | null | ○ |
| fact | status | src |
|---|---|---|
| Series A, $47.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |